Atea Pharmaceuticals, Inc. · NASDAQ:AVIR
Atea Pharmaceuticals, Inc. shareholders
As of Sep 30, 2026, 122 institutions reported holding Atea Pharmaceuticals, Inc., 73.6% of its shares. Largest: Fidelity, BlackRock and BML Capital Management, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Atea Pharmaceuticals, Inc. | Change | Filed |
|---|---|---|---|---|
| Fidelity | 12M | 15.0% | +26,640 | Nov 10, 2026 |
| BlackRock | 9.06M | 11.3% | +341K | Nov 13, 2026 |
| BML Capital Management, LLC | 6.75M | 8.4% | −199K | Nov 6, 2026 |
| Tang Capital Management LLC | 4.81M | 6.0% | no change | Nov 16, 2026 |
| Vanguard | 4.04M | 5.0% | −48,005 | Nov 13, 2026 |
| Acadian Asset Management LLC | 2.34M | 2.9% | +303K | Nov 9, 2026 |
| Bain Capital Life Sciences Investors, LLC | 2.08M | 2.6% | no change | Nov 16, 2026 |
| Geode Capital | 1.91M | 2.4% | −48,146 | Nov 6, 2026 |
| State Street | 1.63M | 2.0% | −25,461 | Nov 12, 2026 |
| Two Sigma | 1.3M | 1.6% | −203K | Nov 16, 2026 |